Rosetta Genomics Ltd. — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$9.2M

Net Income/Loss (FY2016)

$16.2M

Total Assets (FY2016)

$12.0M

Total Equity (FY2016)

$4.4M

Cash Flows from Operating Activities (FY2016)

-$10.4M

Source: Rosetta Genomics Ltd. 20-F filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.